News

Mar 21, 2019
Researchers used a Markov model to compared liver resection with transarterial chemoembolization (TACE) for cirrhotic patients with resectable intermediate-stage hepatocellular carcinoma. | Read More
Mar 14, 2019
A combined microsphere sizing strategy seemed technically feasible and had a promising toxicity profile and effectiveness measures, researchers reported. | Read More
Mar 12, 2019
Researchers undertook a meta-analysis to determine safety and efficacy of partial nephrectomy versus cryoablation for treatment of patients with T1 renal masses. | Read More
Mar 07, 2019
The researchers undertook the study to better understand oncologic and toxicity outcomes from a combined approach to treatment. | Read More
Feb 28, 2019
Patients with advanced biliary tract cancer may potentially be treated with tremelimumab in combination with microwave ablation, according to a pilot study. | Read More
Feb 26, 2019
Researchers assessed the efficacy and safety of Y-90 in 33 patients with metastatic pancreatic adenocarcinoma. | Read More
Feb 21, 2019
To investigate the feasibility of SABR, investigators prospectively recruited 147 patients with oligometastatic cancer to the study. | Read More
Feb 14, 2019
Researchers have developed a prognostic score that can help to stratify candidates for transarterial chemoembolization (TACE), according to a study published in the Journal of Hepatology. | Read More
Feb 12, 2019
Patients with hepatocellular carcinoma and gross vascular invasion may have improved overall survival after being treated with dual modality radiation with external beam radiation therapy (EBRT) and transarterial radioembolization (TARE). | Read More
Feb 07, 2019
Results of a phase II trial suggest that image-guided high-dose-rate (HDR) brachytherapy (iBT) may lead to better outcomes than conventional transarterial embolization (cTACE) in treating unresectable hepatocellular carcinoma (HCC). | Read More